Journal of Cutaneous Medicine and Surgery最新文献_第8页

Keloid. 瘢痕疙瘩。

IF 3.1 4区医学

Journal of Cutaneous Medicine and Surgery Pub Date : 2025-07-15 DOI: 10.1177/12034754251355598

Yi-Xiao Wang, Min Gao

引用次数: 0

Photographic Assessment of the Anatomic Localization and Extent of Hidradenitis Suppurativa: A Delphi Study. 化脓性汗腺炎解剖定位及程度的摄影评估：德尔菲研究。

IF 3.1 4区医学

Journal of Cutaneous Medicine and Surgery Pub Date : 2025-07-14 DOI: 10.1177/12034754251355183

Marissa S Ceresnie, Brittani Jones, Albert T Young, Nasro A Isaq, Olayemi Sokumbi, Iltefat H Hamzavi, Afsaneh Alavi

{"title":"Photographic Assessment of the Anatomic Localization and Extent of Hidradenitis Suppurativa: A Delphi Study.","authors":"Marissa S Ceresnie, Brittani Jones, Albert T Young, Nasro A Isaq, Olayemi Sokumbi, Iltefat H Hamzavi, Afsaneh Alavi","doi":"10.1177/12034754251355183","DOIUrl":"https://doi.org/10.1177/12034754251355183","url":null,"abstract":"Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease with fluctuating activity that requires long-term visual documentation to evaluate disease severity and treatment response. A standardized protocol for photographing HS is critically needed.Objectives: To establish a standardized protocol for using photography to clinically document HS.Methods: We brought together a panel of international experts and used a modified Delphi process to reach consensus on statements about standardized practices for using photography to document HS in clinical practice and research settings. A 75% agreement level was prespecified as the cutoff for consensus.Results: Consensus for photographically documenting HS was developed within 6 key areas: patient preparation, background, lighting, size and reference scale, camera considerations, and patient positioning. The revised and optimized protocol includes 34 standardized reference illustrations. However, the proposed recommendations are for ideal scenarios, and their implementation may not always be practical in a clinical setting. Variations in resources may not have been captured.Conclusions: The proposed consensus-based protocol provides a standard for consistent photographic documentation of HS. This protocol may help clinicians provide better disease surveillance and patient care, and it may aid in more precise and reliable research and clinical trials for HS.","PeriodicalId":15403,"journal":{"name":"Journal of Cutaneous Medicine and Surgery","volume":" ","pages":"12034754251355183"},"PeriodicalIF":3.1,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144626425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Off-Label Topical Application of Sirolimus (Rapamycin) for Dermatological Conditions. 西罗莫司（雷帕霉素）用于皮肤疾病的说明书外局部应用。

IF 3.1 4区医学

Journal of Cutaneous Medicine and Surgery Pub Date : 2025-07-14 DOI: 10.1177/12034754251355595

Tatiana Lapa, Matt Sandre

{"title":"Off-Label Topical Application of Sirolimus (Rapamycin) for Dermatological Conditions.","authors":"Tatiana Lapa, Matt Sandre","doi":"10.1177/12034754251355595","DOIUrl":"https://doi.org/10.1177/12034754251355595","url":null,"abstract":"This review summarizes the off-label applications of topical sirolimus (rapamycin) for dermatological conditions beyond its approved use for angiofibromas associated with tuberous sclerosis, focusing on efficacy, safety, and reported adverse effects. Off-label use of mammalian target of rapamycin inhibitors like sirolimus has shown promising potential in dermatology. We analyzed the literature on the efficacy and safety of topical sirolimus for a range of dermatological conditions, including inflammatory eruptions, genodermatoses, bullous disorders, neoplasms, and others. Publications on topical sirolimus for other vascular anomalies, such as lymphatic malformations, were excluded to maintain focus on other lesser-known dermatological uses, except for studies involving post-laser combination therapies for vascular lesions. Topical sirolimus demonstrated notable efficacy in several genetic and benign proliferative skin disorders, including pachyonychia congenita, trichilemmomas, trichoepitheliomas, and Kaposi sarcoma, with a generally favorable safety profile and minimal systemic absorption. However, variability in formulations, dosing regimens, and the predominance of small-scale studies limit definitive conclusions. Further research is warranted to standardize treatment protocols and validate these findings.","PeriodicalId":15403,"journal":{"name":"Journal of Cutaneous Medicine and Surgery","volume":" ","pages":"12034754251355595"},"PeriodicalIF":3.1,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144626424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Odontogenic Fistula. 牙原性的瘘。

IF 3.1 4区医学

Journal of Cutaneous Medicine and Surgery Pub Date : 2025-07-12 DOI: 10.1177/12034754251355599

María Elena Cornax, Elisabeth Gómez-Moyano

引用次数: 0

Nail Pathology: Median Canaliform Dystrophy of Heller. 指甲病理：海勒中端管状营养不良。

IF 3.1 4区医学

Journal of Cutaneous Medicine and Surgery Pub Date : 2025-07-12 DOI: 10.1177/12034754251355600

Ghassan Barnawi, Osamah Roshdy

引用次数: 0

Dermatitis Artefacta: A Study of 42 Patients with Management Considerations. 人工皮炎：42例治疗要点的研究。

IF 3.1 4区医学

Journal of Cutaneous Medicine and Surgery Pub Date : 2025-07-12 DOI: 10.1177/12034754251355589

Paula Gerlero, Nycolle L K O Guedes, Alexandre J Dwan, Marcello M S Nico

{"title":"Dermatitis Artefacta: A Study of 42 Patients with Management Considerations.","authors":"Paula Gerlero, Nycolle L K O Guedes, Alexandre J Dwan, Marcello M S Nico","doi":"10.1177/12034754251355589","DOIUrl":"https://doi.org/10.1177/12034754251355589","url":null,"abstract":"Background: Dermatitis artefacta (DA) is a primary psychiatric disorder in which patients self-inflict skin lesions to attract the attention of family members to release emotions or simply gain compensation. Studies involving patients with DA are difficult to conduct because patients typically move from one hospital to another. Moreover, very little has been written about its treatment, as most published series of cases have been presented without reporting the follow-up.Objectives: To study the characteristics and therapeutic results in patients with dermatitis artefacta followed up at a university medical centre in Brazil.Methods: We performed a retrospective study of patients with dermatitis artefacta at a dermatological university clinic. The medical records were reviewed to obtain personal data and treatment findings.Results: Forty-two patients were included in this study. Twenty patients were treated with placebo pills plus topical treatments, 14 patients received no treatment, and four patients used only topical treatment. The follow-up period for these patients ranged from a single visit to 7 years. Psychiatric interviews were conducted without the presence of a dermatologist in only a few cases.Conclusions: A dermatologist is a healthcare professional who should be prepared to diagnose and manage cases of DA, and referral to a psychiatrist is usually unsuccessful. The success of the treatment depends on how the doctor approaches the patient. The use of placebo pills may help some patients adhere to treatment and strengthen their therapeutic bonds.","PeriodicalId":15403,"journal":{"name":"Journal of Cutaneous Medicine and Surgery","volume":" ","pages":"12034754251355589"},"PeriodicalIF":3.1,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144618128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Global Registry of Adverse Clinical Events (GRACE^©): A Prospective, Multicenter, Observational Cohort Evaluating Complications Associated With Aesthetic Injectables. 不良临床事件全球登记（GRACE©）：一项评估美容注射相关并发症的前瞻性、多中心、观察性队列研究。

IF 3.9 4区医学

Journal of Cutaneous Medicine and Surgery Pub Date : 2025-07-01 Epub Date: 2025-01-23 DOI: 10.1177/12034754241311270

Kaitlyn M Enright, Andreas Nikolis, John Sampalis

{"title":"Global Registry of Adverse Clinical Events (GRACE©): A Prospective, Multicenter, Observational Cohort Evaluating Complications Associated With Aesthetic Injectables.","authors":"Kaitlyn M Enright, Andreas Nikolis, John Sampalis","doi":"10.1177/12034754241311270","DOIUrl":"10.1177/12034754241311270","url":null,"abstract":"Background: A review of Health Canada's post-market surveillance database has revealed that the reporting of adverse events (AEs) following aesthetic injectable treatments is significantly underreported. To increase reporting, investigators have recently developed a novel Electronic Data Capture system: The Global Registry of Adverse Clinical Events (GRACE©).Objective: To identify the incidence of AEs associated with aesthetic injectable treatments.Methods: Aesthetic clinicians from 10 Canadian sites were recruited. Demographic and clinical data were recorded within the database, which included over 45 patient variables.Results: Throughout the active phase of the trial (duration: 27 months), 123,124 injectable treatments were conducted. One hundred and eleven patients, experiencing a total of 235 AEs, were entered into the portal. This equated to an AE incidence rate of 0.19%, per treatment. Thirty unique products were associated with AEs. In total, there were 112/235 (47.66%) mild, 88/235 (37.45%) moderate, and 35/235 (14.90%) severe AEs. The most common complication (n = 48/235; 20.43%) was swelling, with a prevalence of 0.04%. Of the documented AEs, only 5 were reported to other sources, including 1 case being reported to Health Canada and 4 cases to the respective product manufacturer.Conclusions: The initial feasibility of a registry assessing safety outcomes following injectable treatment has been demonstrated. Findings support that the implementation of the GRACE Portal is an effective outreach strategy for increasing AE reporting by health care professionals. The data represent a more accurate depiction of the safety profile of approved aesthetic injectables in Canada.","PeriodicalId":15403,"journal":{"name":"Journal of Cutaneous Medicine and Surgery","volume":" ","pages":"362-368"},"PeriodicalIF":3.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304487/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143028513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Foundations of Canadian Indigenous Medicine (Part II): Traditional Dermatologic First Aid Practices in First Nations and Inuit Communities in Canada. 加拿大土著医学基础（第二部分）：加拿大第一民族和因纽特人社区的传统皮肤急救实践。

IF 3.9 4区医学

Journal of Cutaneous Medicine and Surgery Pub Date : 2025-07-01 Epub Date: 2025-06-24 DOI: 10.1177/12034754251341847

Nadine Elias Dababneh, Said Dababneh, Samantha Barakat, Josie Cox, William Chiskamish, Alexandra Sarah Victoria Kelly, Sammy Pootoo, Putulik Ilisituk, Mary Sala, Parsa Kitishimik, Serena Weetaltuk, Annie Kumarluk, Richard Moorhouse, Martha Inukpuk, Michael Lefson, Ivan V Litvinov

{"title":"Foundations of Canadian Indigenous Medicine (Part II): Traditional Dermatologic First Aid Practices in First Nations and Inuit Communities in Canada.","authors":"Nadine Elias Dababneh, Said Dababneh, Samantha Barakat, Josie Cox, William Chiskamish, Alexandra Sarah Victoria Kelly, Sammy Pootoo, Putulik Ilisituk, Mary Sala, Parsa Kitishimik, Serena Weetaltuk, Annie Kumarluk, Richard Moorhouse, Martha Inukpuk, Michael Lefson, Ivan V Litvinov","doi":"10.1177/12034754251341847","DOIUrl":"10.1177/12034754251341847","url":null,"abstract":"Background: In Indigenous communities, health transcends physical well-being, embracing harmony between the mind, spirit, body, and emotions. This holistic approach is deeply intertwined with traditional healing practices that draw upon the natural environment to promote well-being. Rooted in a rich cultural heritage and Indigenous knowledge systems, these therapeutic approaches create comprehensive wellness paradigms that honour both ancestral wisdom and biodiversity.Objective: The aim of this review was to identify and analyze the prevalent plants employed by Indigenous communities for first aid dermatologic practices. This effort seeks to create a detailed reference promoting a holistic therapeutic framework.Methodology: A literature review of published articles containing text/keywords such as \"First Nations\" OR \"Traditional medicine\" was first conducted by searching the PubMed database. Additionally, the Native American Ethnobotany Database was systematically searched to gather plant and natural source-based remedies used by Indigenous communities in Canada.Results: A total of 173 plant species were identified through our analysis. These species were utilized for various purposes such as treating sores, wounds, bruises, cuts, sprains, burns, and bites.Conclusion: Combining Indigenous knowledge of traditional medicine and Western clinical practices plays an important role in improving health and treatment outcomes in Indigenous patients and should be openly discussed to foster trust and improve compliance with a mutually derived treatment plan.","PeriodicalId":15403,"journal":{"name":"Journal of Cutaneous Medicine and Surgery","volume":" ","pages":"NP41-NP47"},"PeriodicalIF":3.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

GLP-1 Agonists in Patients With Hidradenitis Suppurativa: A Case Series. GLP-1激动剂在化脓性汗腺炎患者中的应用：一个病例系列。

IF 3.9 4区医学

Journal of Cutaneous Medicine and Surgery Pub Date : 2025-07-01 Epub Date: 2025-02-18 DOI: 10.1177/12034754251320045

Melissa M Rames, Afsaneh Alavi, Nessa Aghazadeh

引用次数: 0

Clinical Features and Treatment of Sebaceous Carcinoma: A Systematic Review. 皮脂腺癌的临床特征和治疗：系统综述。

IF 3.9 4区医学

Journal of Cutaneous Medicine and Surgery Pub Date : 2025-07-01 Epub Date: 2025-02-10 DOI: 10.1177/12034754251316541

Thomas Sabljic, Edgar Akuffo-Addo, Morgan Muncey-Buckley, Leah Johnston, Samantha Y Starkey, Daniel Josué Guerra Ordaz, Sophie Khaslavsky, Angela Burleigh, Richard I Crawford, Ilya Mukovozov

引用次数: 0